SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.[1]
- Market Cap ₹ 1,66,425 Cr.
- Current Price ₹ 1,659
- High / Low ₹ 2,133 / 1,608
- Stock P/E 62.7
- Book Value ₹ 205
- Dividend Yield 0.16 %
- ROCE 15.0 %
- ROE 13.7 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 8.10 times its book value
- The company has delivered a poor sales growth of 6.52% over past five years.
- Tax rate seems low
- Earnings include an other income of Rs.2,003 Cr.
- Dividend payout has been low at 12.2% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance Life Insurance
Part of Nifty 50 BSE 500 BSE 100 BSE 200 BSE Dollex 200
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 131,988 | 116,888 | 112,315 | 121,160 | |
| 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 78,713 | 129,884 | 115,469 | 111,451 | 120,271 | |
| Operating Profit | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 1,923 | 2,104 | 1,420 | 864 | 889 |
| OPM % | 3.4% | 4.8% | 3.5% | 3.9% | 3.3% | 3.1% | 1.1% | 0.9% | 2.4% | 1.6% | 1.2% | 0.8% | 0.7% |
| 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 51 | 50 | 1,357 | 1,948 | 2,003 | |
| Interest | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 76 | 84 | 115 | 0 |
| Profit before tax | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,078 | 2,693 | 2,697 | 2,892 |
| Tax % | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | 9% | 10% | 8% | |
| 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,413 | 2,470 | 2,656 | |
| EPS in Rs | 8.15 | 8.44 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 | 26.47 |
| Dividend Payout % | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% | 11% | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 7% |
| 3 Years: | 12% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 7% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 | 1,002 | 1,003 | 1,003 |
| Reserves | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 13,907 | 15,983 | 18,083 | 19,536 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 70,064 | 78,696 | 96,687 | 115,193 | 139,157 | 156,837 | 216,430 | 261,715 | 301,582 | 383,369 | 440,110 | 480,960 | 517,836 | |
| Total Liabilities | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,277 | 457,095 | 500,046 | 538,375 |
| 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 520 | 551 | 580 | 647 | 735 | |
| CWIP | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 6 | 10 | 41 | 0 |
| Investments | 69,385 | 77,843 | 95,830 | 114,436 | 139,325 | 158,813 | 218,756 | 264,437 | 304,334 | 385,590 | 447,467 | 486,367 | 526,359 |
| 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,743 | 12,130 | 9,038 | 12,991 | 11,281 | |
| Total Assets | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,277 | 457,095 | 500,046 | 538,375 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | 25,547 | 34,523 | |
| -178 | -7,204 | -9,032 | -8,910 | -13,552 | -16,986 | -19,203 | -21,611 | -30,203 | -31,221 | -21,789 | -35,318 | |
| -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 | -215 | -179 | |
| Net Cash Flow | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,114 | 4,677 | 10 | -1,962 | -2,327 | 3,543 | -974 |
| Free Cash Flow | 2,687 | 5,600 | 8,377 | 10,288 | 13,325 | 19,210 | 23,763 | 21,785 | 28,581 | 29,008 | 25,441 | 34,338 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 341% | 628% | 798% | 780% | 955% | 1,473% | 2,802% | 3,094% | 1,532% | 1,426% | 1,870% | 4,112% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 0 | -6 | 3 | 3 | 4 | 11 | 1 | -3 | 1 | 4 | 2 | 4 |
| ROCE % | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% | 15% | 17% | 15% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 13th Month Persistency % |
|
|||||||||
| Annualized Premium Equivalent (APE) ₹ billion |
||||||||||
| APE Channel Mix - Bancassurance % % |
||||||||||
| APE Product Mix - ULIP % % |
||||||||||
| Number of Insurance Agents count |
||||||||||
| Number of Offices count |
||||||||||
| Private Market Share (IRP) % |
||||||||||
| Individual New Business Sum Assured ₹ billion |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Audio Recording - Earnings Calls For Q2 Of FY 2026-27
- Audio recording of Q2 FY2026-27 earnings call hosted on company website on October 27, 2026.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- SBI Life reported H1 FY27 PAT ₹12.7 billion, APE ₹117.5 billion, VoNB ₹32.7 billion on Oct 27, 2026.
-
Financial Results For The Quarter Ended September 30, 2026
- Board approved Q2 and H1 FY2027 unaudited results; postal ballot for Nihar Jambusaria’s independent director appointment.
-
Board Meeting Outcome for Board Meeting Of SBI Life Insurance Company Limited Held On October 27, 2026
- Board approved Q2 and half-year FY2026 unaudited results; postal ballot for independent director appointment.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Earnings call on October 27, 2026 at 19:00 IST for H1 FY2027 results.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
Concalls
-
Oct 2026PPT REC
-
Jul 2026Transcript PPT REC
-
Apr 2026Transcript PPT REC
-
Apr 2026PPT
-
Feb 2026Transcript PPT
-
Oct 2025Transcript PPT REC
-
Jul 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
Jun 2023PPT
-
May 2023Transcript
-
Jan 2023Transcript
-
Nov 2022Transcript
-
Aug 2022Transcript
-
May 2022Transcript
-
May 2020PPT
-
Jan 2018PPT
Product Portfolio
The company offers a range of life insurance products, including 25 individual and 8 group plans across protection, pension, savings, and health solutions. Its portfolio includes participating, non-participating, pension, gratuity, leave encashment, superannuation, annuity, unit-linked, variable, health, and micro-insurance products. [1][2]